Topping the charts

We list the world’s ten biggest selling medicines in 2019

Humira (Adalimumab) remained the world’s biggest selling medicine, in monetary terms, in 2019.

The treatment for carious forms of arthritis, Crohn’s Disease and other treatments had global sales of US$19.74 billion (Aus$26.088 bn) in 2019, according to figures collated and published by US pharmaceutical industry publication Fierce Pharma.

Just behind the Abbvie manufactured blockbuster were a range of oncology treatments. Merck’s Keytruda is currently in second place, and is tipped to take the top spot in the next few years.

According to the report, Keytruda is expected to reach sales of US$25 billion (Aus$37,28 bn) by 2026. 

The top ten best-selling medicines globally for 2019 were:

  1. Humira
  2. Keytuda
  3. Revlimid
  4. Opdivo
  5. Eylea
  6. Eliquis
  7. Enbrel
  8. Avastin
  9. Stelara
  10. Rituxan

Following behind these on the lsit are medicines such as Xarelto (11th), Herceptin (12th) and Prevnar (13th).

Six of the top 20 drugs faced generic or biosim challengers for the first time in 2019 or previously saw copycats hit the market. 

Roche saw its three bestselling oncology medicines—Avastin, Herceptin and Rituxan—all facing US competitors in 2019. 

Previous Cash, drugs stolen from former employer in ‘moment of weakness’
Next ‘On the day, I won’t be alone.’

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.